Education
About Us
Working with TipRanks
Follow Us
10X Genomics (TXG)
:TXG
10x Genomics (TXG) Ownership Overview
2.14% Insiders
24.90% Mutual Funds
38.35% Other Institutional Investors
24.87% ETFs
9.74% Public Companies and
Individual Investors
The ownership structure of 10x Genomics (TXG) stock is a mix of institutional, retail, and individual investors. Approximately 88.12% of the company’s stock is owned by Institutional Investors, 2.14% is owned by Insiders, and 9.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 26, 2025 | Serge Saxonov Ceo,director | xxxxxxxxxxxxx | $56318 |
| Feb 26, 2025 | Benjamin J. Hindson President And Chief Scientific Officer,director | xxxxxxxxxxxxx | $50577 |
| Feb 25, 2025 | Alan Mateo Evp Global Sales | xxxxxxxxxxxxx | $445200 |
| Nov 25, 2024 | Serge Saxonov Ceo,director | xxxxxxxxxxxxx | $91560 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $264066 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1832336 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $21496920 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $47092198 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,067,973 | Institution | 11.15% | 124,782,841 | |
| 11,944,057 | Institution | 11.03% | 123,501,549 | |
| 9,351,055 | Institution | 8.64% | 96,689,909 | |
| 8,877,300 | Institution | 8.20% | 91,791,282 | |
| 4,482,400 | Institution | 4.14% | 46,348,016 | |
| 3,279,401 | Institution | 3.03% | 33,909,006 | |
| 2,884,661 | Institution | 2.66% | 29,827,395 | |
| 2,432,740 | Institution | 2.25% | 25,154,532 | |
| 1,912,100 | Institution | 1.77% | 19,771,114 | |
| 1,672,200 | Institution | 1.54% | 17,290,548 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,877,300 | Institution | 8.20% | 91,791,282 | |
| 4,482,400 | Institution | 4.14% | 46,348,016 | |
| 1,672,200 | Institution | 1.54% | 17,290,548 | |
| 1,660,230 | Institution | 1.53% | 17,166,778 | |
| 1,066,598 | Institution | 0.99% | 11,028,623 | |
| 868,775 | Institution | 0.80% | 8,983,134 | |
| 867,207 | Institution | 0.80% | 8,966,920 | |
| 793,300 | Institution | 0.73% | 8,202,722 | |
| 698,053 | Institution | 0.64% | 7,217,868 | |
| 695,536 | Institution | 0.64% | 7,191,842 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,940,623 | Institution | 8.26% | 92,446,042 | |
| 3,183,101 | Institution | 2.94% | 34,027,350 | |
| 3,032,168 | Institution | 2.80% | 31,352,617 | |
| 2,588,493 | Institution | 2.39% | 37,170,759 | |
| 1,646,279 | Institution | 1.52% | 17,598,723 | |
| 1,463,144 | Institution | 1.35% | 21,947,160 | |
| 610,243 | Institution | 0.56% | 6,309,913 | |
| 498,980 | Institution | 0.46% | 4,929,922 | |
| 415,482 | Institution | 0.38% | 4,296,084 | |
| 349,755 | Institution | 0.32% | 3,616,467 |
FAQ
Who Owns 10X Genomics (TXG)?
According to the latest TipRanks data, approximately 38.35% of the company's stock is held by institutional investors, 2.14% is held by insiders, and 9.74% is held by retail investors.
What percentage of 10X Genomics (TXG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.35% of 10X Genomics (TXG) stock is held by institutional investors.
What percentage of 10X Genomics (TXG) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.74% of 10X Genomics (TXG) stock is held by retail investors.
Who owns the most shares of 10X Genomics (TXG)?
ARK owns the most shares of 10X Genomics (TXG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.